Yahoo Web Search

Search results

1. • 

     Brilinta (Ticagrelor) vs. Plavix (Clopidogrel): Which Is Better?

     Verywell Health via Yahoo News· 6 months ago

     Brilinta (ticagrelor) and Plavix (clopidogrel) are blood-thinning medications, also called blood...

2. • 

     12 Commonly Prescribed Blood Thinners

     Verywell Health via Yahoo News· 2 months ago

     Medically reviewed by Alex Yampolsky, PharmD Blood thinners are a type of medication that prevents blood clots from forming in the body. There are two...

3. • 

     Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 3 months ago

     Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript March 14, 2024 Cytosorbents...

4. • 

     AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?

     Zacks via Yahoo Finance· 1 year ago

     AstraZeneca’s AZN stock has risen 5.1% in the past year compared with an increase of 2% for the...

5. • 

     AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab

     Zacks via Yahoo Finance· 1 year ago

     AstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...

6. • 

     AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales

     Zacks via Yahoo Finance· 1 year ago

     AstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...

7. • Q2 2023 Cytosorbents Corp Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 10 months ago

     Participants Christian Steiner; EVP of Sales & Marketing; Cytosorbents Corporation Christopher Cramer; VP of Business Development; Cytosorbents Corporation Efthymios N. Deliargyris; Chief Medical ...

8. • 

     Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine

     Zacks via Yahoo Finance· 2 years ago

     This week, AstraZeneca AZN and Sanofi’s SNY RSV vaccine, nirsevimab and Sanofi and GSK’s GSK...

9. • 

     Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say

     Zacks via Yahoo Finance· 1 month ago

     While the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...

10. • 

      PhaseBio Might Have To Return Global Rights To Its Lead Program

      Benzinga via Yahoo Finance· 2 years ago

      PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) received a notice that its partner SFJ Pharmaceuticals...